Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging.

Zhou Z, Han Z, Lu ZR.

Biomaterials. 2016 Apr;85:168-79. doi: 10.1016/j.biomaterials.2016.02.002. Epub 2016 Feb 3.

2.

Hybrid PET/optical imaging of integrin αVβ3 receptor expression using a (64)Cu-labeled streptavidin/biotin-based dimeric RGD peptide.

Kang CM, Koo HJ, An GI, Choe YS, Choi JY, Lee KH, Kim BT.

EJNMMI Res. 2015 Dec;5(1):60. doi: 10.1186/s13550-015-0140-0. Epub 2015 Oct 31.

3.

F-18 Labeled RGD Probes Based on Bioorthogonal Strain-Promoted Click Reaction for PET Imaging.

Kim HL, Sachin K, Jeong HJ, Choi W, Lee HS, Kim DW.

ACS Med Chem Lett. 2015 Feb 6;6(4):402-7. doi: 10.1021/ml500464f. eCollection 2015 Apr 9.

4.

Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.

Tsiapa I, Loudos G, Fragogeorgi EA, Bouziotis P, Psimadas D, Xanthopoulos S, Paravatou-Petsotas M, Palamaris L, Varvarigou AD, Karnabatidis D, Kagadis GC.

Cancer Biother Radiopharm. 2014 Dec;29(10):444-50. doi: 10.1089/cbr.2014.1672.

5.

Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency.

Mendez N, Herrera V, Zhang L, Hedjran F, Feuer R, Blair SL, Trogler WC, Reid TR, Kummel AC.

Biomaterials. 2014 Nov;35(35):9554-61. doi: 10.1016/j.biomaterials.2014.08.010. Epub 2014 Aug 22.

6.

Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides.

Yang Y, Ji S, Liu S.

Bioconjug Chem. 2014 Sep 17;25(9):1720-9. doi: 10.1021/bc500309r. Epub 2014 Aug 21.

7.

Biodistribution of (99m)tc labeled integrin antagonist.

Jang BS, Park SH, Shin IS, Maeng JS, Paik CH.

Toxicol Res. 2013 Mar;29(1):21-5. doi: 10.5487/TR.2013.29.1.021.

8.

Synchrotron X-ray fluorescence studies of a bromine-labelled cyclic RGD peptide interacting with individual tumor cells.

Sheridan EJ, Austin CJ, Aitken JB, Vogt S, Jolliffe KA, Harris HH, Rendina LM.

J Synchrotron Radiat. 2013 Mar;20(Pt 2):226-33. doi: 10.1107/S0909049513001647. Epub 2013 Feb 7.

9.

(68)Ga-Labeling of RGD peptides and biodistribution.

Blom E, Velikyan I, Estrada S, Hall H, Muhammad T, Ding C, Nair M, Långström B.

Int J Clin Exp Med. 2012;5(2):165-72. Epub 2012 Apr 6.

10.

Post-coupling strategy enables true receptor-targeted nanoparticles.

Chen J, Jorgensen MR, Thanou M, Miller AD.

J RNAi Gene Silencing. 2011;7:449-55. Epub 2011 Sep 15.

11.

New Methods for Labeling RGD Peptides with Bromine-76.

Lang L, Li W, Jia HM, Fang DC, Zhang S, Sun X, Zhu L, Ma Y, Shen B, Kiesewetter DO, Niu G, Chen X.

Theranostics. 2011;1:341-53. Epub 2011 Aug 22.

12.

Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates.

Ray A, Larson N, Pike DB, Grüner M, Naik S, Bauer H, Malugin A, Greish K, Ghandehari H.

Mol Pharm. 2011 Aug 1;8(4):1090-9. doi: 10.1021/mp100402n. Epub 2011 Jun 1.

13.
14.

PET Imaging of Integrin αVβ3 Expression.

Beer AJ, Kessler H, Wester HJ, Schwaiger M.

Theranostics. 2011 Jan 17;1:48-57.

15.

MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.

Jacobson O, Zhu L, Niu G, Weiss ID, Szajek LP, Ma Y, Sun X, Yan Y, Kiesewetter DO, Liu S, Chen X.

Mol Imaging Biol. 2011 Dec;13(6):1224-33. doi: 10.1007/s11307-010-0458-y.

16.

Molecular imaging in cancer treatment.

Michalski MH, Chen X.

Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):358-77. doi: 10.1007/s00259-010-1569-z. Epub 2010 Jul 27. Review.

17.

Preclinical molecular imaging of tumor angiogenesis.

Zhu L, Niu G, Fang X, Chen X.

Q J Nucl Med Mol Imaging. 2010 Jun;54(3):291-308. Review.

18.

Positron emission tomography tracers for imaging angiogenesis.

Haubner R, Beer AJ, Wang H, Chen X.

Eur J Nucl Med Mol Imaging. 2010 Aug;37 Suppl 1:S86-103. doi: 10.1007/s00259-010-1503-4. Review.

19.

Tc-labeling of Peptidomimetic Antagonist to Selectively Target alpha(v)beta(3) Receptor-Positive Tumor: Comparison of PDA and EDDA as co-Ligands.

Shin IS, Maeng JS, Jang BS, You E, Cheng K, Li KC, Wood B, Carrasquillo JA, Danthi SN, Paik CH.

Curr Radiopharm. 2010 Jan 1;3(1):1-8.

20.

(18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.

Liu Z, Yan Y, Liu S, Wang F, Chen X.

Bioconjug Chem. 2009 May 20;20(5):1016-25. doi: 10.1021/bc9000245.

Supplemental Content

Support Center